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The pathogenesis of listeriosis results mainly from the ability of Listeria monocytogenes
to attach, invade, replicate and survive within various cell types in mammalian tissues. In
this work, the effect of two bacteriocin-producing Carnobacterium (C. divergens V41 and
C. maltaromaticum V1) and three non-bacteriocinogenic strains: (C. divergens V41C9,
C. divergens 2763, and C. maltaromaticum 2762) was investigated on the reduction of
L. monocytogenes Scott A plaque-forming during human infection using the HT-29 in
vitro model. All Carnobacteria tested resulted in a reduction in the epithelial cell invasion
caused by L. monocytogenes Scott A. To understand better the mechanism underlying
the level of L. monocytogenes infection inhibition by Carnobacteria, infection assays
from various pretreatments of Carnobacteria were assessed. The results revealed the
influence of bacteriocin production combined with a passive mechanism of mammalian
cell monolayers protection by Carnobacteria. These initial results showing a reduction
in L. monocytogenes virulence on epithelial cells by Carnobacteria would be worthwhile
analyzing further as a promising probiotic tool for human health.
Keywords: foodborne pathogens, Carnobacterium divergens, Carnobacterium maltaromaticum, bacteriocin,
HT29, mucus layer
INTRODUCTION
Listeria monocytogenes is one of the major foodborne pathogens responsible for listeriosis.
The infections in high-risk individuals, such as pregnant women, newborn infants and
immunocompromised people may cause meningitis, encephalitis, septicemia or spontaneous late-
term abortions with a mortality rate as high as 30% (Farber and Peterkin, 1991; Rocourt et al., 2000;
Vázquez-Boland et al., 2001; Swaminathan and Gerner-Smidt, 2007). In 2013, 1763 human cases
of listeriosis were reported in Europe by the European Food Safety Authority and the European
Center for Disease Prevention and Control (EFSA and ECDC, 2015). The notification rate was 0.44
cases per 100,000 population which represented an 8.6% increase compared with 2012 (EFSA and
ECDC, 2015). There was a statistically significant increase in the incidence of listeriosis over the
period 2009–2013. In total, 191 deaths due to listeriosis were reported in 2013, with the highest
number (64 cases) occurring in France. L. monocytogenes is therefore of public concern in terms
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of food safety and regulations to control this microorganism.
Currently, antibiotics are the most accepted treatment option
for listeriosis infections. As vaccination is unavailable and the
use of antibiotics is declining due to an increase in resistance
and allergies, there is a need for innovative alternative ways of
reducing L. monocytogenes infections in humans.
L. monocytogenes is wide spread in the environment and has
been isolated from various sources such as dairy products, fresh
vegetables, and meats (Beresford et al., 2001; Guerrieri et al.,
2009). Isolations performed in the food processing environment
reveal that L. monocytogenes can adhere to inert surfaces and
grow as biofilms in diverse areas, such as dead ends, crevices and
corner cracks (Kim and Frank, 1995; Tresse et al., 2006, 2007; Shi
and Zhu, 2009; Pilchová et al., 2014; Guilbaud et al., 2015). Due
to the ability of this pathogenic bacterium to grow in foodstuffs at
refrigerated temperatures, efficient control methods are required
to limit the risk in ready-to-eat food products with a long shelf
life. As increasing numbers of consumers prefer foods without
chemical preservatives (Cleveland et al., 2001; Devlieghere et al.,
2004), there is an opportunity for methods focusing on the use
of a protective culture such as lactic acid bacteria (LAB). The
protective LAB could produce antimicrobial metabolites such
as lactic acid, diacetyl, hydrogen peroxide and bacteriocin or
bacteriocin-like compounds (Lindgren and Dodrogosz, 1990).
Some bacteriocin-producing LAB have demonstrated
their efficiency in limiting the growth of L. monocytogenes
(Harris et al., 1989; Rodriguez et al., 1997; Laukova et al., 1999;
Ennahar et al., 2000; Sabia et al., 2002; Tyopponen et al., 2003;
Todorov et al., 2011; Amado et al., 2012). Carnobacterium spp.
are among the bacteriocin-producing bacteria recently studied
as protective cultures in foodstuffs. The Carnobacterium genus
belongs to the family Carnobacteriaceae within the order of
Lactobacillales and currently consists of 12 species (Euzéby,
1997). Two of the Carnobacterium species, C. divergens and C.
maltaromaticum, are mainly isolated from the environment and
foods (Leisner et al., 2007). Both have been shown to exhibit a
wide spectrum of activity against L. monocytogenes which has
been attributed in some cases to the production of bacteriocins
(Pilet et al., 1995; Buchanan and Bagi, 1997; Duffes et al., 1999;
Nilsson et al., 1999; Schöbitz et al., 1999; Yamazaki et al., 2003;
Józefiak et al., 2010). Attempts to apply extracted bacteriocins
against L. monocytogenes have been limited due to (i) the loss of
activity following bacteriocin purification steps, (ii) variations in
bacteriocin production depending on Carnobacterium spp. and
(iii) variations in susceptibility among L. monocytogenes strains
(Richard et al., 2003; Brillet et al., 2004). Non-bacteriocinogenic
strains have also demonstrated inhibitory activity toward L.
monocytogenes (Nilsson et al., 2005). Some in vitro experiments
on the antagonism of various LAB against pathogenic bacteria
have been reported (Alemka et al., 2010; Garnier et al., 2010;
Messaoudi et al., 2012). Although, the active ingredients
were mainly attributed to the production of bacteriocins, the
inhibitory effect of Carnobacteria on L. monocytogenes virulence
has not yet been explored.
In this study, we examined the in vitro potential of protective
Carnobacterium strains to assess their effect on the virulence of
L. monocytogenes. Bacteriocin- and non-bacteriocin-producing
Carnobacterium strains were tested on cell line models using
HT29 and its mucin-producing counterpart HT29-MTX.
MATERIALS AND METHODS
Bacterial Strains
Two clinical strains of L. monocytogenes and five strains of
Carnobacterium spp. were used in this study. L. monocytogenes
Scott A (serotype 4b) and L. monocytogenes LO28 (serotype 1/2c)
were previously isolated from listeriosis outbreaks, C. divergens
V41, and C. maltaromaticum V1 (formerly C. piscicola) were
isolated from salmon and trout intestine and characterized by
Pilet et al. (1995), C. divergens V41C9 is a C. divergens V41
mutant deficient in divercin production (Richard et al., 2003),
C. divergens NCDO 2763 and C. maltaromaticum (formerly C.
piscicola) NCDO 2762 (type strain) were obtained from the
National Collection of Dairy Organisms (Reading, UK). All
strains were stored in cryotubes at−80◦C in brain heart infusion
broth (BHI) for L. monocytogenes strains and in Elliker broth
for Carnobacterium strains supplemented with 20% glycerol as
a cryoprotectant.
Antimicrobial Activity Determination
The antimicrobial activity of Carnobacterium strains was tested
on two L. monocytogenes strains using the agar diffusion assay
(Pilet et al., 1995). Briefly, the L. monocytogenes subculture was
grown in BHI broth for 8 h at 37◦C and culture was incubated
overnight at 37◦C. A concentration of 3.5 × 107 cfu ml−1 was
mixed to the BHI agar. Carnobacterium strains were subcultured
in Elliker broth for 24 h at 20◦C. Cultures were then incubated
overnight at 20◦ and 30◦C. Similar concentrations of bacteria
were obtained after cultivation at 20◦ and 30◦C (2.6 × 109 cfu
ml−1 and 1.8 × 109 cfu ml−1). The cell-free supernatant of each
Carnobacterium strain was obtained by centrifugation (8200 g,
10 min at 4◦C) and 10 µl of the filtered supernatant (untreated
supernatant and treated culture supernatant adjusted to pH 6.5)
was then spotted onto indicator plates of BHI agar (1%) seeded
with 106 cfu ml−1 of the target strain. After overnight incubation
at 37◦C, the presence of a translucent halo corresponding to the
absence of L. monocytogenes growth was observed.
Cell Line Cultures
The human adenocarcinoma cell line HT29 and the mucus-
secreting HT29 cells selected by adaptation to methotrexate
(HT29-MTX) were used. HT29-MTX cells were obtained from
Dr Thécla Lesuﬄeur (INSERM UMR S 938, Paris France)
(Lesuﬄeur et al., 1993). Cells were routinely grown in 25
cm2 plastic tissue culture flasks (Nunc, Life Technologies) in
5 ml of culture medium (Dulbecco’s modified Eagle’s medium;
DMEM; Eurobio, Courtaboeuf, France) supplemented with 10%
(v/v) fetal calf serum (Eurobio, Courtaboeuf, France), 2 mM
L-glutamine (Eurobio, Courtaboeuf, France) and antibiotics—
penicillin 100 IU ml−1 and streptomycin 100 µg ml−1 (Sigma,
France). Antibiotics were routinely added to the culture medium
except for virulence assays. Cells weremaintained in a humidified
incubator (at least 90% RH) at 37◦C under 5% (v/v) CO2
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(SANYO Electric Co., Ltd., Osaka, Japan). The medium was
changed every other day.
L. monocytogenes Plaque-Forming Assay
(PFA)
The ability of L. monocytogenes Scott A to form lysis plaques
on cell lines HT29 and HT29-MTX was assessed using the
PFA as previously described by Roche et al. (2001). Briefly,
cell monolayers were grown until they reached 90% confluence
in DMEM supplemented with antibiotics and then without
antibiotics for another 24 h. The overnight L. monocytogenes
cultures, grown in BHI broth, were appropriately diluted in
DMEM without antibiotics. The 96-wells were inoculated with
2 to 8 log CFU L. monocytogenes per well in triplicate and
incubated for 2 h at 37◦C in a humidified incubator and treated
with 100 µg ml−1 gentamicin (Sigma, France). After 1.5 h of
incubation, cell monolayers were overlaid with an agarose gel
containing 0.48% indubiose (Bio-Rad Laboratories, France) in
DMEM supplemented with 10 µg ml−1 of gentamicin. The
number of plaques was counted with a microscope after 48 h of
incubation at 37◦C in a humidified incubator. Each experiment
was repeated three times from independent cultures for each
strain and the results were expressed as the number of plaques
obtained for 7 or 8 log L. monocytogenes loaded per well.
Ability of C. divergens to Adhere to
Epithelial Cells HT29
After cultivation, C. divergens V41 and V41C9 were harvested by
centrifugation, resuspended in DMEM without antibiotics and
serum at a concentration of 108 cfuml−1 and loaded on confluent
HT29 and HT29-MTX cell line monolayers. After 1 h or 4 h of
incubation (37◦C, 5%CO2), monolayers were washed three times
with PBS to remove nonadherent bacteria and lysed with 0.1%
Triton X100 for 15min. The lysate was then diluted and plated on
Elliker agar plates to determine the number of adherent bacteria.
Each experiment was performed in duplicate.
PFA in the Presence of Carnobacterium
Carnobacterium strains were grown as described above. Cultures
were pelleted by centrifugation at 8200 g for 10 min and
resuspended in DMEM medium without antibiotics. A total of
100 µl of Carnobacterium culture in tissue culture medium was
used to coat the cells with 109 cfu ml−1 for 1 h or 4 h at 37◦C.
After the initial incubation period, 100 µl of L. monocytogenes
culture at 107 or 108 cfu ml−1 was added on the cell monolayers
and incubated for 2 h at 37◦C. Then, the medium was replaced
with 100 µl of fresh sterile culture medium containing 100 µg
ml−1 gentamicin and incubated for another 1.5 h at 37◦C. Next,
the same steps as mentioned above were performed to count
the number of lysis plaques. As controls, L. monocytogenes and
Carnobacterium strains were also tested separately on HT29 and
HT29-MTX cell lines. Each experiment was repeated three times
from independent cultures for each strain.
Pretreatment of Carnobacterium before
Infection Assays
Cell monolayers were originally incubated with probiotic cultures
at 109 cfu ml−1 in antibiotic-free medium. To cover wide
range of active compounds that could potentially affect the
listerial invasion, six different pretreatments were applied to
the Carnobacterium culture: (a) 1 ml of an overnight culture
of Carnobacteria strains was centrifuged (8200 g for 10 min)
and the cells obtained in the pellet were resuspended in 1 ml
of DMEM (namely—resuspended cells—RS); (b) 1 ml of an
overnight culture of Carnobacterium was centrifuged (8200 g for
10 min) and the cells obtained in the pellet were washed in 1 ml
of DMEM, centrifuged once more and subsequently resuspended
in 1 ml of DMEM (namely—washed cells—WS); (c) 1 ml of an
overnight culture was heated at 100◦C for 5 min, centrifuged
(8200 g for 10 min) and the cells in the pellet resuspended in
1 ml of DMEM (namely—resuspended heated cells—RHC); (d)
1 ml of an overnight culture was heated at 100◦C for 5 min,
centrifuged (8200 g for 10 min) and the cells were washed in 1
ml of DMEM, centrifuged once more time and then resuspended
in 1 ml of DMEM (namely—washed heated cells—WHC); (e)
overnight cultures were centrifuged (8200 g for 10 min) and cell-
free supernatant was adjusted to pH 6.5 and then either untreated
(namely—non-filtered supernatant—NFS), or filtered (0.2 µm
filter; namely—filtered supernatant—FS).
Statistical Analyses
The data were analyzed using Statgraphics Centurion XVI
software (StatPoint Inc., Herndon, Virginia, USA). With the
confirmation of a normal distribution for each data set,
significant differences were determined using two-sided Student’s
t-test comparisons at a 5% significance level.
RESULTS
Effect of Bacteriocin-Producing
C. divergens V41 on L. monocytogenes
Using In vitro Virulence Models
First, the antimicrobial activity of the divercin-producing
C. divergens V41 (div+) and its non-bacteriocinogenic mutant
C. divergens V41C9 (div−) against L. monocytogenes was
confirmed (Table 1). As expected, the growth of Scott A and
LO28 was inhibited by supernatants of the div+ strain cultivated
at 20◦ and 30◦C while no inhibition zone was observed for the
div− strain in all conditions. Identical results observed with pH-
neutralized supernatants confirmed the divercin action of V41
against L. monocytogenes (Table 1). In the following experiments,
the effect of Carnobacteria against L. monocytogenes virulence
was assessed using Scott A as it is more virulent than LO28.
Plaque-forming on confluent monolayer epithelial cells by L.
monocytogenes Scott A was evaluated after 1 h of C. divergens
V41 inoculation (Figure 1). No plaque was observed when C.
divergens V41 was loaded alone indicating the absence of a
cytotoxic effect by C. divergens on HT29 and HT29 MTX cell
lines. In contrast, L. monocytogenes Scott A was able to form
plaques on both cell lines with a higher level on HT29 cells (log
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TABLE 1 | Growth inhibition of L. monocytogenes Scott A and LO28 by
C. divergens.
Scott A LO28
Untreated supernatant
V41 (20◦C) + +
V41 (30◦C) + +
V41C9 (20◦C) − −
V41C9 (30◦C) − −
Supernatant adjusted to pH 6.5
V41 (20◦C) + +
V41 (30◦C) + +
V41C9 (20◦C) − −
V41C9 (30◦C) − −
Supernatants of cultures at 20◦ and 30◦C of the bacteriocin-producing strain C. divergens
V41 and its non-bacteriocinogenic variant V41C9 were tested. Growth inhibition was
measured using the agar diffusion test as shown in the picture for Scott A with the cell-free
culture supernatant of V41 at 20◦C (lane I) and at 30◦C (lane II). Neutralized supernatants
were obtained by adjusting the pH to 6.5.
+, inhibition zone ≥ 3 mm; −, inhibition zone < 3 mm.
3.27± 0.12 plaques) than on their mucus-secreting counterparts
(log 2.80 ± 0.0.08). The significant difference between the two
cell lines indicates a role of mucus in the prevention of L.
monocytogenes plaque-forming. When Scott A was inoculated
on epithelial cells previously coated with C. divergens V41, the
plaque-forming ability of Scott A was reduced dramatically on
both cell lines. At 108 cfu ml−1, plaque-forming by Scott A
decreased to log 0.44 on HT29 and to log 0.29 on HT29 MTX
while at 107 cfu ml−1, the plaque-forming of Scott A was reduced
to an undetectable level on both lines. Furthermore, when the
supernatant (filtered-FS and not filtered-NFS) of V41 culture was
used, a similar inhibitory effect on Scott A plaque-forming was
obtained on both cell lines.
Comparative Effect of Bacteriocinogenic
and Non-bacteriocinogenic C. divergens
Strains on L. monocytogenes Scott A In
vitro Virulence
In order to determine the contribution of the bacteriocin
(divercin) secreted by C. divergens V41 to the inhibition of
L. monocytogenes plaque-forming, the div− mutant, defective
in bacteriocin synthesis, was tested. When the HT29 cells
were precoated with the div− strain, the inhibitory level of
L. monocytogenes plaque-forming only decreased to 91.5%
indicating a major contribution by another factor besides that of
bacteriocin (Table 2). From now on, the antimicrobial effects will
be named “the bacteriocin effect” for those due to bacteriocins
and “protective effect” for those independent of bacteriocins. The
inhibition of plaque-forming by the div− strain was significantly
lower than that of div+ on both cell lines confirming a slight
FIGURE 1 | Inhibition of L. monocytogenes Scott A plaque-forming by
C. divergens V41 using epithelial cells HT29 and mucus-secreting
HT29 MTX. C. divergens (Cdiv) was loaded at 109 cfu ml−1 1 h before L.
monocytogenes Scott A inoculation at 107 or 108 cfu ml−1 and incubated for
2 h on HT29 confluent cells. Supernatants (filtered FS or non-filtered NFS) of
C. divergens culture were also tested. No plaque-forming was observed when
Cdiv was loaded alone. Results represent the mean PFA of L. monocytogenes
Scott A (Lm Scott A) ± SD from at least three independent experiments.
Asterisks indicate significant differences (P < 0.05) compared to Scott A alone
(*), between L. monocytogenes inocula (**) and between HT29 and HT29 MTX
(***). As no significant difference in plaque-forming was observed after loading
Scott A alone at 107 or 108 cfu ml−1, these results were pooled (n = 6).
TABLE 2 | Comparison of the inhibiting efficiency of
bacteriocin-producing strain C. divergens 41 (div−) and the
non-bacteriocin-producing strain V41C9 (div−) on L. monocytogenes
Scott A plaque-forming on HT29 and mucus-secreting HT29 MTX.
C. divergens L. monocytogenes
(cfu ml−1)
HT29 HT29-MTX
Mean ± SD (%) Mean ± SD (%)
V41 (div+) Scott A (107) 100.0± 0.0 100.0± 0.0
V41 (div+) Scott A (108) 86.5± 6.3 89.1± 1.7
V41C9 (div−) Scott A (107) 91.5± 6.6* 98.7± 2.7
V41C9 (div−) Scott A (108) 74.9± 4.4* 81.7± 3.2*
Carnobacteria were inoculated at 109 cfu ml-1. HT29 and HT29 MTX epithelial cells were
precoated with Carnobacteria 1 h before the inoculation of L. monocytogenes at 107
or 108cfu ml-1. Results were normalized to the plaques obtained with L. monocytogenes
Scott A alone (log 3.27± 0.12, n= 4 on HT29 and log 2.80± 0.08, n= 4 on HT29 MTX).
The means and standard deviations (SD) were calculated from at least three independent
experiments. Asterisks indicate significant differences (P < 0.05) between div+ and div−.
but significant contribution of the bacteriocin effect in the div+
strain (Table 2). In addition, a lower plaque-forming inhibition
was observed on HT29 MTX for Scott A at 108 cfu/mL
which confirms the role of the mucus observed in Figure 1 in
preventing L. monocytogenes plaque-forming (Table 2).
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Influence of Precoating Time C. divergens
on the Inhibition of L. monocytogenes
Scott A Infection Using HT29 and
HT29-MTX Cell Lines
The ability of strains div+ and div− to adhere to host cells
was assessed by incubating the culture for 1 h and 4 h on
confluent monolayers of HT29 and HT29-MTX (Figure 2). The
initial C. divergens concentration loaded onto cell monolayers
was 109 cfu ml−1. Overall, approximately 5 × 107 cfu ml−1
of viable C. divergens cells were recovered from cell lysates. A
significantly greater number of adherent cells was observed on
HT29-MTX than on HT29 indicating a positive effect of mucus
on C. divergens adhesion (Figure 2). In addition, a decrease,
although moderate, was observed in the adhesion of div+ after
4 h of contact on both cell lines compared to 1 h while adhesion
tended to increase for div− on HT29-MTX. When assessed in
the presence of L. monocytogenes Scott A, there was no significant
difference between 1 and 4 h of contact except for div− after 4 h
of contact on HT29MTXwhich showed less inhibition of Scott A
plaque-forming compared to 1 h (Table 3). Taken together, these
results indicate that C. divergens V41 remains efficient against
Scott A after 4 h of contact with both cell lines by maintaining
both its protective and bacteriocin effects.
Effect of Various Pretreatments of
C. divergens V41 on the Inhibition of
L. monocytogenes Scott A Plaque-Forming
on HT29
To understand further the protective mode of action of
C. divergens V41, additional infection assays with various
FIGURE 2 | Viability of Carnobacterium strains on epithelial cells after
4 h of contact time with HT29 and HT29-MTX epithelial cell model. The
bacteriocin-producing strain C. divergens V41 (div+) and the
non-bacteriocinogenic strain V41C9 (div−) were inoculated at 109 cfu ml−1.
Results represent the mean ± SD from three independent experiments.
Asterisks indicate significant differences (P < 0.05) between 1 and 4 h of
precoating (*) and between HT29 and HT29 MTX (**).
pretreatments were carried out (Figure 3). The results showed
no significant difference in plaque-forming by L. monocytogenes
when cells were washed and/or heated before inoculation on
HT29, indicating that no extracellular divercin remained after the
preparation of the div+ culture and that dead cells were able to
achieve the same efficient protective effect.
Effect of Carnobacterium spp. on the
Inhibition of L. monocytogenes
Plaque-Forming on HT29
In order to determine if the protective effect of Carnobacterium
against L. monocytogenes is specific to C. divergens V41,
additional strains or species were tested (Figure 4). The
anti-listerial activity of cell-free neutralized supernatants of
C. maltaromaticum V1 was confirmed (inhibition zone =
10mm ± 0; n = 3 at 20◦C and 9 mm ± 1; n = 3 at 30◦C) while
the supernatants of non-bacteriocinogenic strains C. divergens
2763 and C. maltaromaticum 2762 did not exhibit any growth
inhibition of L. monocytogenes Scott A (inhibition zone < 3 mm;
n = 3 at 20◦ and 30◦C; Figure 4A). All five Carnobacterium
strains tested, bacteriocinogenic or not, significantly inhibited
the number of plaques formed by L. monocytogenes Scott A
(Figure 4B). However, the decrease in plaque-forming was lower
for all strains compared to that of div+ indicating a better
potential of C. divergens V41 to prevent L. monocytogenes
infection. In line with what was observed with V41 and its div−
mutant, the bacteriocin-producing C. maltaromaticum V1 was
significantly more efficient at limiting the number of plaques
formed by L. monocytogenes than the non-bacteriocin-producing
strain C. maltaromaticum 2762. Similar results obtained with
washed or preheated cells confirmed that inhibition of Scott A
plaque-forming by Carnobacteria can utilize both bacteriocin
and protective effects.
DISCUSSION
The inhibitory effect of two bacteriocin-producing Carnobacteria
(C. divergens V41 and C. maltaromaticum V1) and three
non-bacteriocin-producing Carnobacteria (C. divergens V41C9,
C. divergens 2763 and C. maltaromaticum 2762) against
TABLE 3 | Effect of precoating contact time of Carnobacterium strains on
the inhibition of L. monocytogenes plaque-forming on HT29 and HT29
MTX.
Contact time of
C. divergens (h)
HT29 HT29 MTX
1 4 1 4
V41 (div+)/Scott A 100.0± 0.0 97.0± 3.1 100.0± 0.0 100.0± 0.0
V41C9 (div−)/Scott A 91.5± 6.6 82.8± 9.9 98.7± 2.7 82.4± 2.6*
L. monocytogenes cells were inoculated at 107 cfu ml-1 1h or 4 h after the inoculation
of C. divergens V41 (div+) or V41C9 (div−) at 109 cfu ml-1. Results were normalized to
the plaques obtained with L. monocytogenes Scott A (log 3.29 ± 0.13, n = 4 on HT29
and log 2.79 ± 0.08, n = 4 on HT29 MTX). The means and standard deviations (SD)
were calculated from at least three independent experiments. Asterisks indicate significant
difference (P < 0.05) between 1 and 4 h of precoating.
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FIGURE 3 | Inhibition of L. monocytogenes Scott A plaque-forming by
pretreated C. divergens V41 using the HT29 epithelial cell model. C.
divergens V41 was inoculated at 109 cfu ml−1 1 h before inoculating L.
monocytogenes at 107 cfu ml−1. (RC) control without pretreatment; (WC)
washed cells; (RHC) resuspended heated cells and (WHC) washed heated
cells. The results are expressed as mean ± SD from two independent
experiments. Asterisks indicate significant differences (P < 0.05) compared to
Scott A alone. No significant difference was observed between treatments and
the control (P > 0.05).
pathogenic L. monocytogenes strains has previously been
investigated in food (Pilet et al., 1995; Richard et al., 2003;
Brillet et al., 2004, 2005). The use of C. divergens V41 and
C. maltaromaticum V1 could represent an alternative strategy to
control the growth of L. monocytogenes in cold-smoked salmon
(Brillet et al., 2004). Overall, LAB isolated from salmon intestine
resulted in growth inhibition of Aeromonas salmonicida with no
reduction in the mortality rate of the fish (Gildberg et al., 1995).
Several methods have been proposed to assess the virulence
of L. monocytogenes. Mouse infection models have demonstrated
their efficiency in differentiating virulent from non-virulent
strains (Roche et al., 2001); nonetheless their use is limited
due to ethical considerations. Expression of the main virulence
genes hlyA, actA, inlA, and prfA using RT-qPCR has also been
investigated to show the effect of environmental conditions on
virulence factor transcript levels of L. monocytogenes (Duodu
et al., 2010). However, the plaque-forming assay using HT29
cells is usually proposed as the best alternative to animal models
as it takes into account the epithelial cell invasion capability
of the pathogen (Roche et al., 2001). In this work, HT29 cell
assays were completed by mucus-secreting HT29 MTX cells in
order to include the potential role of mucus in bacterial invasion
capability.
A significant reduction in L. monocytogenes virulence on
epithelial cells was observed when the cell monolayers were
precoated with C. divergens V41 cultures during 1 or 4 h.
The capability to limit foodborne pathogen virulence has
previously been tested for probiotic LAB and found to be
strain-specific. For instance, Garriga et al. (2015) reported
that only bacteriocinogenic Lactobacillus sakei of 5 other LAB
tested significantly reduced the adhesion of L. monocytogenes.
Lactobacillus and Bifidobacterium were also shown to inhibit
significantly the subsequent listerial infection using the in vitro
C2Bbe1 epithelial cell model (Corr et al., 2007). Pretreatment
of intestinal cells T 84 with LAB prevents injury of Escherichia
coliO157:H7 and E. coliO157:H6 induced by attaching-effacing-
Lactobacillus species (Sherman et al., 2005). In the case of
Campylobacter jejuni, the leading cause of bacterial foodborne
diseases (EFSA and ECDC, 2015; Turonova et al., 2015),
adhesion, internalization and translocation of HT29 cells were
attenuated by strains of Lactobacillus rhamnosus, Lactobacillus
helveticus, and Lactobacillus salivarius (Alemka et al., 2010). The
authors reported that live LAB and prolonged precolonization of
mammalian cells with probiotics is a prerequisite for probiotic
action against Campylobacter virulence. More recently, Srividya
et al. (2015) demonstrated an in vitro inhibition of 70% of Shigella
dysentariae by a probiotic lactic acid bacterial lysate.
In this study, to investigate the mechanism that could be
involved in the efficiency of counteracting L. monocytogenes
Scott A by Carnobacterium, comparisons were made between
the divercin-producing C. divergens V41 (div+) and C. divergens
V41C9 (div−), a mutant defective in divercin production
(Richard et al., 2003). As expected, div− did not show any
inhibitory effect on L. monocytogenes cultured on plates in
accordance with previous studies (Pilet et al., 1995; Richard
et al., 2003). In addition, div+ supernatants resulted in a
similar inhibitory effect on plaque-forming by L. monocytogenes
indicating the efficiency of divercin on L. monocytogenes during
invasion assays. Nonetheless, both div+ and div− were able to
reduce dramatically L. monocytogenes plaque-forming on HT29
and HT29 MTX cell lines. The effect of the div+ strain was
slightly but significantly higher than that obtained with div−
indicating the contribution of bacteriocin activity by the div+
strain since the adhesion rate of both protective cultures was
similar on both cell line models. Another bacteriocin-producing
C. maltaromaticum V1 was also more efficient at limiting the
number of plaques formed by L. monocytogenes than the non-
bacteriocinogenic strain counterpart (C. maltaromaticum 2762).
This work indicates that non-bacteriocinogenic Carnobacteria
strains are also effective candidates for limiting the pathogenicity
of L. monocytogenes using the combined effects of bacteriocin
activity and mammalian cell protection. The preheated cell
treatment suggests that the protective effect of Carnobacteria
could be attributed to a passive mechanism. A significant
inhibition of L. monocytogenes adhesion, invasion and
transepithelial translocation was obtained using Lactobacillus
paracasei but only if this strain was recombined to obtain the
expression of Listeria adhesion protein (LAP, Lmo1634) in order
to interact specifically with the host cell receptor Hsp60 (Koo
et al., 2012). In our study, an inhibitory effect of L. monocytogenes
virulence by Carnobacterium was obtained without genetically
engineered strains. This could be explained by an increase in
epithelial barrier functions due to an interaction with secreted
components (Shen et al., 2005). Inhibition mechanisms could
also involve specific proteins that accumulate on the cell-surface
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FIGURE 4 | Inhibition of L. monocytogenes Scott A plaque-forming by Carnobacteria using the HT29 epithelial cell model. Two bacteriocin-producing
strains (C. divergens V41 and C. maltaromaticum V1 and three non-bacteriocinogenic strains (C. divergens V41C9, C. divergens 2763, C. maltaromaticum 2762)
were compared. (A) Capabilities to inhibit growth of L. monocytogenes Scott A by C. divergens V1, C. divergens 2763, C. maltaromaticum 2762. Growth inhibition
was measured using the agar diffusion test at 20◦ and at 30◦C. Neutralized supernatants were obtained by adjusting pH to 6.5. (B) Each Carnobacterium strain was
inoculated at 109 cfu ml−1 on HT29 cells 1 h before loading L. monocytogenes at 107 cfu ml−1. Pretreatments were as follow: control without pretreatment (RC);
washed cells (WC); resuspended heated cells (RHC); and washed heated cells (WHC). The results are expressed as mean ± SD from two independent experiments.
Plaque-forming by L. monocytogenes Scott A alone was log 3.52 ± 0.21, n = 4. All Carnobacteria significantly inhibited plaque-forming by L. monocytogenes Scott
A. Asterisks indicate significant differences (P < 0.05) compared to C. divergens V41.
as described for Streptococcus pneumoniae (Guiral et al., 2005).
However, further analyses are required to unravel the protective
effect of mammalian cells by Carnobacteria.
We also observed that the mucus layer enhanced the impact
of the protective effect of Carnobacteria. This was correlated to a
significantly higher number of adherent cells. Similar results were
obtained by Alemka et al. (2010) who reported the contribution
of the mucus layer to the potential efficacy of probiotic treatment
for the attenuation of C. jejuni pathogenicity. Mucus constitutes
a physical and chemical protective barrier of epithelial cells.
Its complex composition includes electrolytes, plasma proteins,
lipids, nucleic acids and a large variety of high molecular weight
glycoproteins called mucins that contribute to the viscoelasticity
of mucus (Johansson et al., 2011). The mucus is a sheltering
interspace for bacteria protecting them from shearing motions
due to intestinal peristalsis. In addition, commensal bacteria
trapped in the mucus are less motile and could be organized
into biofilms reinforcing epithelial cell protection (Zoetendal
et al., 2002). Weak interactions between mucus and bacterial
cell surfaces such as hydrophilic/hydrophobic bonds or cell
appendages such as pili could also contribute to maintaining cells
in sheltering interspace (Douillard et al., 2013).
Carnobacteria did not alter HT29 cells indicating the absence
of cytotoxicity. For their potential use as protective cultures
in food, the question of human the safety of these LAB
arises. Carnobacteria are not known as members of the human
gastrointestinal microbial community like several other LAB.
Previous studies have shown that they do not present an
imminence for human illnesses, nor for nosocomial infections
in hospitals (Leisner et al., 2007). The genome sequence of the
type strain of C. maltaromaticum NCDO2762 (ATCC35586)
has shown potential virulence factors but none of the specific
virulence factors that are present in L. monocytogenes strains and
it was thus concluded that there are no human safety concerns for
this species (Leisner et al., 2012). The whole genome sequence
of C. divergens V41 is now being annotated and analyzed in
our laboratory for further research on its harmlessness. In
addition, C. maltaromaticum and C. divergens are considered
microorganisms with technological beneficial use according to
Bourdichon et al. (2012). Recently, C. divergens was added
to the authoritative list of microorganisms with a QPS status
(qualified presumption of safety) validated by EFSA for the
safety risk assessment of microorganisms intentionally added to
food and feed (EFSA, 2014). In the USA, the Food and Drug
Administration (FDA) provides a notice inventory of substances
that have been approved in terms of safety namely substances
generally recognized as safe (GRAS) based the on specific usage
and dosage for each substance. This inventory lists viable bacteria
including C. maltaromaticum (FDA, 2015).
In conclusion, this work demonstrates the potential probiotic
effect of Carnobacterium strains to attenuate the pathogenesis of
L. monocytogenes Scott A. The probiotic mechanism results from
a bacteriocin effect combined to a protective effect of mammalian
cells. Probiotics have positive effects on human health and
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general well-being. They have been historically associated with
cultured milk and dairy products. More recently, they have been
analyzed for their potential to inhibit pathogenic and spoilage
microorganisms (Klaenhammer, 2000; Gill and Guarner, 2004;
Grover et al., 2012).
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